Clinical Patterns of Primary Biliary Cholangitis: Comparison Between Two European Case Series.

IF 1.4 Q4 PHARMACOLOGY & PHARMACY
Ludovico Abenavoli, Anna Caterina Procopio, Pietro Cinaglia, Christian Zanza, Claudio Delle Grazie, Yaroslava Longhitano, Pavla Libicherova, Francesco Luzza
{"title":"Clinical Patterns of Primary Biliary Cholangitis: Comparison Between Two European Case Series.","authors":"Ludovico Abenavoli,&nbsp;Anna Caterina Procopio,&nbsp;Pietro Cinaglia,&nbsp;Christian Zanza,&nbsp;Claudio Delle Grazie,&nbsp;Yaroslava Longhitano,&nbsp;Pavla Libicherova,&nbsp;Francesco Luzza","doi":"10.2174/1574887117666220617095856","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of the intrahepatic bile ducts, followed by fibrous substitution of the ducts and potential evolution in cirrhosis. The geographical disparity in the prevalence of PBC suggests a possible role of environmental factors in developing the disease. We analyzed two groups of patients with different geographical prevalence.</p><p><strong>Methods: </strong>This study concerned the analysis of 14 Caucasian patients in two groups: ten patients enrolled in the Digestive Diseases Unit, University of Catanzaro (Italy), and four patients enrolled in the Department of Hepatology, University Hospital Kràlovskè Vinohrady of Prague (Czech Republic). The statistical analysis was performed using the software IBM SPSS (v. 20, Windows).</p><p><strong>Results: </strong>The Italian group showed a statistically significant difference in the total bilirubin values at diagnosis and during the last control (0.74±0.267 vs. 0.56±0.246; p-value: 0.013). Moreover, the comparison between the two groups showed a statistically significant difference in the serum albumin values at the time of the last control (4.6±0.231 vs. 4.15±0.532; p-value: 0.048).</p><p><strong>Conclusion: </strong>Our data indicate an effective difference in the onset and clinical presentation between our two groups. More epidemiologic, prospective, and multicenter research projects are warranted to advance PBC knowledge in Europe.</p>","PeriodicalId":21174,"journal":{"name":"Reviews on recent clinical trials","volume":"17 2","pages":"136-142"},"PeriodicalIF":1.4000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews on recent clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574887117666220617095856","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of the intrahepatic bile ducts, followed by fibrous substitution of the ducts and potential evolution in cirrhosis. The geographical disparity in the prevalence of PBC suggests a possible role of environmental factors in developing the disease. We analyzed two groups of patients with different geographical prevalence.

Methods: This study concerned the analysis of 14 Caucasian patients in two groups: ten patients enrolled in the Digestive Diseases Unit, University of Catanzaro (Italy), and four patients enrolled in the Department of Hepatology, University Hospital Kràlovskè Vinohrady of Prague (Czech Republic). The statistical analysis was performed using the software IBM SPSS (v. 20, Windows).

Results: The Italian group showed a statistically significant difference in the total bilirubin values at diagnosis and during the last control (0.74±0.267 vs. 0.56±0.246; p-value: 0.013). Moreover, the comparison between the two groups showed a statistically significant difference in the serum albumin values at the time of the last control (4.6±0.231 vs. 4.15±0.532; p-value: 0.048).

Conclusion: Our data indicate an effective difference in the onset and clinical presentation between our two groups. More epidemiologic, prospective, and multicenter research projects are warranted to advance PBC knowledge in Europe.

原发性胆道胆管炎的临床特点:两个欧洲病例系列的比较。
背景:原发性胆道胆管炎(PBC)是一种慢性自身免疫性胆汁淤积性肝病,其特征是肝内胆管的进行性破坏,随后是纤维替代胆管,并可能演变为肝硬化。PBC患病率的地域差异表明,环境因素可能在该病的发生中起作用。我们分析了两组不同地域患病率的患者。方法:本研究涉及两组14例高加索患者的分析:10例患者入组于卡坦扎罗大学(意大利)消化疾病科,4例患者入组于布拉格大学医院Kràlovskè Vinohrady肝脏内科。采用IBM SPSS (v. 20, Windows)软件进行统计分析。结果:意大利组在诊断时和末次对照期间总胆红素值差异有统计学意义(0.74±0.267∶0.56±0.246;假定值:0.013)。两组最后一次对照时血清白蛋白值比较,差异有统计学意义(4.6±0.231∶4.15±0.532;假定值:0.048)。结论:我们的数据表明两组在发病和临床表现上有明显的差异。需要更多的流行病学、前瞻性和多中心研究项目来推进欧洲的PBC知识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reviews on recent clinical trials
Reviews on recent clinical trials PHARMACOLOGY & PHARMACY-
CiteScore
3.10
自引率
5.30%
发文量
44
期刊介绍: Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics. The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信